Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (3)

2021

  1. Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- And high-risk myeloma

    Blood, Vol. 137, Núm. 1, pp. 49-60

2020

  1. CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation

    Blood Advances, Vol. 4, Núm. 5, pp. 893-906

2017

  1. ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA

    Oncogene, Vol. 36, Núm. 12, pp. 1733-1744